VECTOR TOBACCO LTD has a total of 43 patent applications. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets consumer goods, biotechnology and pharmaceuticals are JAPAN MONOPOLY CORP, US SMOKELESS TOBACCO CO and U S SMOKELESS TOBACCO COMPANY LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Canada | 3 | |
#4 | China | 3 | |
#5 | Israel | 3 | |
#6 | United States | 3 | |
#7 | South Africa | 3 | |
#8 | Argentina | 2 | |
#9 | Australia | 2 | |
#10 | African Regional Industrial Property Organization | 1 | |
#11 | Brazil | 1 | |
#12 | Hong Kong | 1 | |
#13 | Hungary | 1 | |
#14 | Japan | 1 | |
#15 | Republic of Korea | 1 | |
#16 | Mexico | 1 | |
#17 | New Zealand | 1 | |
#18 | Peru | 1 | |
#19 | Poland | 1 | |
#20 | Singapore | 1 | |
#21 | Taiwan | 1 | |
#22 | Uruguay | 1 |
# | Industry | |
---|---|---|
#1 | Consumer goods | |
#2 | Biotechnology | |
#3 | Pharmaceuticals | |
#4 | Basic materials chemistry | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Tobacco | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Preservation of human bodies | |
#6 | Cigarettes | |
#7 | Machines for making cigarettes | |
#8 | New plants | |
#9 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Conkling Mark A | 17 |
#2 | Conkling Mark | 8 |
#3 | Bereman Robert D | 6 |
#4 | Jin Wendy | 2 |
#5 | Mark A Conkling | 2 |
#6 | Darzynkiewicz Zbigniew | 1 |
#7 | Yan Conkling Mark A Li | 1 |
#8 | Cheah Kheng | 1 |
#9 | Xie Jiahua | 1 |
#10 | Jorgensen Ellen D | 1 |
Publication | Filing date | Title |
---|---|---|
WO2005103296A2 | Global gene expression analysis of human bronchial epithelial cells exposed to cigarette smoke, smoke condensates, or components thereof | |
EP1684603A2 | Tobacco product labeling system | |
CA2527648A1 | Method of reducing the harmful effects of orally or transdermally delivered nicotine | |
WO2004076625A2 | Method of identifying plant cells transformed with a gene | |
CA2481167A1 | Tobacco having reduced nicotine and nitrosamines | |
IL159213D0 | Modifying nicotine and nitrosamine levels in tobacco | |
US6789548B2 | Method of making a smoking composition |